$OCUP 125mm biotech w/ 4 shots on goal this year
▪️ February readout in RM (pupil constriction)
▪️ Q2 readout in Presbyopia
▪️ Q3 readout in Night Vision Sensitivities
▪️ Q4 readout in DME/DR

Mkt will likely better appreciate pipeline following the first readout in Mydriasis👇
$OCUP Focusing on Mydriasis, there are over 80mm eye exams per year with many of them involving pupil dilation. Lasting effects of discomfort/blurred vision (6+ hours) following dilation can disturb work flow/driving ability.

Solution: Nyxol for $5 out of pocket @ point of care
$OCUP Nyxol is intended to restore pupil size following routine eye dilatation exams. They demonstrated impressive efficacy in a ph2 trial hitting stat sig for PD at 1hr post tx w/ 1 drop of Nyxol

Post hoc (using ph3 endpt) shows that they hit at 120mins, strong trend at 60min
$OCUP now the FDA wants them to show an effect at 90 minutes post dose for registration. Co has strengthened their odds of success by:
✴️Administering 2 drops (vs 1 drop in ph2)
✴️Much larger sample size, 185 pts (vs 62 in ph2)
✴️Equal stratification 1:1 by iris color

POS =💪
$OCUP A near term win in mydriasis would give the co added momentum as they head into a spell of readouts later in the year

Don't sleep on $OCUP
You can follow @BuysideBiotech.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.